Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 237 | 4,009 | 7,086 | 10,124 | -5,774 |
| Depreciation Amortization | 773 | 549 | 352 | 173 | 660 |
| Accounts receivable | 560 | 695 | 553 | 656 | -751 |
| Accounts payable and accrued liabilities | 236 | 67 | -100 | 96 | -35 |
| Other Working Capital | 216 | -843 | -565 | 312 | -911 |
| Other Operating Activity | 479 | 444 | 412 | -243 | 2,360 |
| Operating Cash Flow | $2,501 | $4,921 | $7,738 | $11,118 | $-4,451 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -30,000 | -30,000 | -30,000 | -30,000 | N/A |
| PPE Investments | -1,395 | -970 | -365 | -123 | -437 |
| Purchase Sale Intangibles | -161 | -112 | -82 | -56 | -82 |
| Other Investing Activity | -161 | 9,888 | -82 | -56 | -82 |
| Investing Cash Flow | $-31,556 | $-21,082 | $-30,447 | $-30,179 | $-519 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -24 |
| Common Stock Issued | 38,760 | 38,618 | 36,871 | 35,513 | 4,489 |
| Financing Cash Flow | $38,760 | $38,618 | $36,871 | $35,513 | $4,465 |
| Exchange Rate Effect | 143 | -10 | -13 | -68 | 60 |
| Beginning Cash Position | 3,526 | 3,526 | 3,526 | 3,526 | 3,971 |
| End Cash Position | 13,374 | 25,973 | 17,675 | 19,910 | 3,526 |
| Net Cash Flow | $9,848 | $22,447 | $14,149 | $16,384 | $-445 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,501 | 4,921 | 7,738 | 11,118 | -4,451 |
| Capital Expenditure | -1,428 | -970 | -365 | -123 | -437 |
| Free Cash Flow | 1,073 | 3,951 | 7,373 | 10,995 | -4,888 |